Cite
HARVARD Citation
Tang, B. et al. (2021). Real-world efficacy and safety of axitinib in combination with anti-programmed cell death-1 antibody for advanced mucosal melanoma. European journal of cancer. pp. 83-92. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tang, B. et al. (2021). Real-world efficacy and safety of axitinib in combination with anti-programmed cell death-1 antibody for advanced mucosal melanoma. European journal of cancer. pp. 83-92. [Online].